Market Cap (In INR)
314.4 Million
Revenue (In INR)
449.24 Million
Net Income (In INR)
4.72 Million
Avg. Volume
8096.00
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 11.68-37.98
- PE
- -786.0
- EPS
- -0.04
- Beta Value
- 0.7860586
- ISIN
- INE858L01010
- CUSIP
- -
- CIK
- -
- Shares
- 10000000.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- -
- Employee Count
- -
- Website
- http://www.concorddrugs.in
- Ipo Date
- 2015-02-23
- Details
- Concord Drugs Ltd. engages in the provision of pharmaceutical formulations. Its products include ready to fill pellets, mup's tissue bio adhesive, injectables, oral solid dosages, oral solid dosages, and liquid orals. The company was founded on April 24, 1995 and is headquartered in Hyderabad, India.
More Stocks
-
VBSN
-
JUBILE
-
TKUN
-
OPESFOtello Corporation ASA
OPESF
-
PENINLANDPeninsula Land Limited
PENINLAND
-
300805
-
RNDOFRound One Corporation
RNDOF
-
DRMTYDr. Martens plc
DRMTY